Along with existing studies, increased CRM1 expression has been reported in tumor tissue compared to the normal tissue of patients with gastric cancer and osteosarcoma, and high expression level has been reported to be associated with clinicopathological parameters and overall survival [17,39]. This evidence concerns the gene XPO1 and osteosarcoma.